{"id":"tp-52923","type":"article-newspaper","title":"ADC Therapeutics Revenue Climbs 32.9% to $21 Million in Third Quarter","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/52923","datePublished":"2026-11-10T08:27:50.000Z","dateModified":"2026-11-10T08:27:50.000Z","language":"en","abstract":"Revenue beat estimates by $1.93 million, while the company posted a non-GAAP loss of $0.06 per share.","section":"Business","references":[]}